Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model

The benefits and harms of breast cancer screening: an independent review

Marmot, M. G. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61611-0 · Cited by 1,495 · see citing works

Association analysis identifies 65 new breast cancer risk loci

Michailidou, K., Lindström, S., Dennis, J., Beesley, J., Hui, S., Kar, S., Lemaçon, A., Soucy, P., Glubb, D. M., Rostamianfar, A., et al. (2017) · Nature · doi:10.1038/nature24284 · Cited by 1,380 · see citing works

Untitled work

Higgins (2002) · doi:10.1002/(issn)1097-0258 · Cited by 1,248 · see citing works

Polygenic susceptibility to breast cancer and implications for prevention

Pharoah, P. D. P., Antoniou, A. C., Bobrow, M., Zimmern, R. L., Easton, D. F., & Ponder, B. A. J. (2002) · Nature Genetics · doi:10.1038/ng853 · Cited by 898 · see citing works

Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States

Maas, P., Barrdahl, M., Joshi, A. D., Auer, P. L., Gaudet, M. M., Milne, R. L., Schumacher, F. R., Anderson, W. F., Check, D., Chattopadhyay, S., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.1025 · Cited by 373 · see citing works

Personalizing Mammography by Breast Density and Other Risk Factors for Breast Cancer: Analysis of Health Benefits and Cost-Effectiveness

Schousboe, J. T., Kerlikowske, K. M., Loh, A., & Cummings, S. R. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-1-201107050-00003 · Cited by 317 · see citing works

Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase

Duffy, S. W., Chen, H., Tabár, L. K., & Day, N. E. (1995) · Statistics in Medicine · doi:10.1002/sim.4780141404 · Cited by 208 · see citing works

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening

Pashayan, N., Duffy, S. W., Chowdhury, S., Dent, T., Burton, H., Neal, D. E., Easton, D. F., Eeles, R. A., & Pharoah, P. D. P. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.118 · Cited by 159 · see citing works

Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort study

Evans, D. G., Astley, S., Stavrinos, P., Harkness, E. F., Donnelly, L. S., Dawe, S., Jacob, I., Harvie, M., Cuzick, J. M., Brentnall, A. R., et al. (2016) · Programme Grants for Applied Research · doi:10.3310/pgfar04110 · Cited by 150 · see citing works

Cost-Effectiveness and Harm-Benefit Analyses of Risk-Based Screening Strategies for Breast Cancer

Vilaprinyó, E., Forné, C., Carles-Lavila, M., Sala, M., Pla, R., Castells, X., Domingo, L., Rué, M., & the Interval Cancer (INCA) Study Group (2014) · PLoS ONE · doi:10.1371/journal.pone.0086858 · Cited by 142 · see citing works

Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes

Trentham‐Dietz, A., Kerlikowske, K. M., Stout, N. K., Miglioretti, D. L., Schechter, C. B., Ergün, M. A., van den Broek, J. J., Alagöz, O., Sprague, B. L., van Ravesteyn, N. T., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m16-0476 · Cited by 126 · see citing works

Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement

Darabi, H., Czene, K., Zhao, W., Liu, J., Hall, P. N., & Humphreys, K. (2012) · Breast Cancer Research · doi:10.1186/bcr3110 · Cited by 122 · see citing works

Combined Associations of Genetic and Environmental Risk Factors: Implications for Prevention of Breast Cancer

García‐Closas, M., Gunsoy, N. B., & Chatterjee, N. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju305 · Cited by 120 · see citing works

Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium

Rudolph, A., Song, M., Brook, M. N., Milne, R. L., Mavaddat, N., Michailidou, K., Bolla, M. K., Wang, Q., Dennis, J., Hurson, A. N., et al. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx242 · Cited by 109 · see citing works

Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis

Pashayan, N., Duffy, S. W., Neal, D. E., Hamdy, F. C., Donovan, J., Martin, R. M., Harrington, P. A., Benlloch, S., Olama, A. A. A., Shah, M., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2014.192 · Cited by 93 · see citing works

Incorporating genomics into breast and prostate cancer screening: assessing the implications

Chowdhury, S., Dent, T., Pashayan, N., Hall, A., Lyratzopoulos, G., Hallowell, N., Hall, P. N., Pharoah, P. D. P., & Burton, H. (2013) · Genetics in Medicine · doi:10.1038/gim.2012.167 · Cited by 91 · see citing works

Cost effectiveness of the NHS breast screening programme: life table model

Pharoah, P. D. P., Sewell, B., Fitzsimmons, D. F., Bennett, H., & Pashayan, N. (2013) · BMJ · doi:10.1136/bmj.f2618 · Cited by 86 · see citing works

Evaluation of a Stratified National Breast Screening Program in the United Kingdom: An Early Model-Based Cost-Effectiveness Analysis

Gray, E., Donten, A., Karssemeijer, N., van Gils, C. H., Evans, D. G., Astley, S., & Payne, K. (2017) · Value in Health · doi:10.1016/j.jval.2017.04.012 · Cited by 69 · see citing works

European Guide on Quality Improvement in Comprehensive Cancer Control

Albreht, T., Amati, C., Angelastro, A., Asioli, M., Amunni, G., Molina‐Barceló, A., Berling, C., Caraceni, A. T., Colamesta, V., Comiskey, K., et al. (2017) · Data Archiving and Networked Services (DANS) · Cited by 69 · see citing works

Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK

Meisel, S. F., Pashayan, N., Rahman, B., Side, L. E., Fraser, L. S. M., Gessler, S., Lanceley, A., & Wardle, J. (2015) · The Breast · doi:10.1016/j.breast.2015.02.001 · Cited by 65 · see citing works

Public interest in and acceptability of the prospect of risk-stratified screening for breast and prostate cancer

Koitsalu, M., Sprangers, M. A. G., Eklund, M., Czene, K., Hall, P. N., Grönberg, H., & Brandberg, Y. (2015) · Acta Oncologica · doi:10.3109/0284186x.2015.1043024 · Cited by 59 · see citing works

Stratified Cancer Screening: The Practicalities of Implementation

Dent, T., Jbilou, J., Rafi, I., Segnan, N., Törnberg, S., Chowdhury, S., Hall, A., Lyratzopoulos, G., Eeles, R. A., Eccles, D., et al. (2013) · Public Health Genomics · doi:10.1159/000345941 · Cited by 48 · see citing works

Screening Men at Increased Risk for Prostate Cancer Diagnosis: Model Estimates of Benefits and Harms

Gulati, R., Cheng, H. H., Lange, P. H., Nelson, P. S., & Etzioni, R. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0434 · Cited by 48 · see citing works

A Reality Check for Overdiagnosis Estimates Associated With Breast Cancer Screening

Etzioni, R., Xia, J., Hubbard, R. A., Weiss, N. S., & Gulati, R. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju315 · Cited by 47 · see citing works

Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC

Pashayan, N., Pharoah, P. D. P., Schleutker, J., Talala, K. M., Tammela, T. L. J., Määttänen, L., Harrington, P. A., Tyrer, J. P., Eeles, R. A., Duffy, S. W., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.289 · Cited by 46 · see citing works

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699 · see citing works

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors

Lee, A., Mavaddat, N., Hurson, A. N., Cunningham, A. P., Carver, T. J., Hartley, S., de Villiers, C. B., Izquierdo, Á., Simard, J., Schmidt, M. K., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-018-0406-9 · Cited by 725 · see citing works

Towards clinical utility of polygenic risk scores

Lambert, S. A., Abraham, G., & Inouye, M. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz187 · Cited by 566 · see citing works

The future of early cancer detection

Fitzgerald, R. C., Antoniou, A. C., Fruk, L., & Rosenfeld, N. (2022) · Nature Medicine · doi:10.1038/s41591-022-01746-x · Cited by 475 · see citing works

Personalized early detection and prevention of breast cancer: ENVISION consensus statement

Pashayan, N., Antoniou, A. C., Ivanuš, U., Esserman, L. J., Easton, D. F., French, D., Sroczynski, G., Hall, P. N., Cuzick, J. M., Evans, D. G., et al. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0388-9 · Cited by 443 · see citing works

Polygenic Risk Scores for Cardiovascular Disease: A Scientific Statement From the American Heart Association

O’Sullivan, J. W., Raghavan, S., Márquez‐Luna, C., Luzum, J. A., Damrauer, S. M., Ashley, E. A., O’Donnell, C. J., Willer, C. J., & Natarajan, P. (2022) · Circulation · doi:10.1161/cir.0000000000001077 · Cited by 424 · see citing works

Circulating cell-free DNA for cancer early detection

Gao, Q., Zeng, Q., Wang, Z., Li, C., Xu, Y., Cui, P., Xin, Z., Lu, H., Wang, G., Cai, S., et al. (2022) · The Innovation · doi:10.1016/j.xinn.2022.100259 · Cited by 156 · see citing works

Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field

Yanes, T., Young, M., Meiser, B., & James, P. A. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01260-3 · Cited by 152 · see citing works

Breast Cancer in Asia: Incidence, Mortality, Early Detection, Mammography Programs, and Risk-Based Screening Initiatives

Lim, Y. X., Lim, Z. L., Ho, P. J., & Li, J. (2022) · Cancers · doi:10.3390/cancers14174218 · Cited by 161 · see citing works

European polygenic risk score for prediction of breast cancer shows similar performance in Asian women

Ho, W.-K., Tan, M., Mavaddat, N., Tai, M.-C., Mariapun, S., Li, J., Ho, P. J., Dennis, J., Tyrer, J. P., Bolla, M. K., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17680-w · Cited by 134 · see citing works

The current status of risk-stratified breast screening

Clift, A. K., Dodwell, D. J., Lord, S., Petrou, S., Brady, M., Collins, P. G. S., & Hippisley‐Cox, J. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01550-3 · Cited by 134 · see citing works

Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I)

Brooks, J. D., Nabi, H., Andrulis, I. L., Antoniou, A. C., Chiquette, J., Després, P., Devilee, P., Dorval, M., Droit, A., Easton, D. F., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060511 · Cited by 120 · see citing works

Family health history: underused for actionable risk assessment

Ginsburg, G. S., Wu, R. R., & Orlando, L. A. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31275-9 · Cited by 105 · see citing works

Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification

Choudhury, P. P., Hurson, A. N., Brook, M. N., Zhang, Y., Ahearn, T. U., Orr, N., Coulson, P., Schoemaker, M. J., Jones, M. E., Gail, M. H., et al. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz113 · Cited by 103 · see citing works

Incorporating carbon into health care: adding carbon emissions to health technology assessments

McAlister, S., Morton, R. L., & Barratt, A. L. (2022) · The Lancet Planetary Health · doi:10.1016/s2542-5196(22)00258-3 · Cited by 99 · see citing works

Precision public health in the era of genomics and big data

Roberts, M. C., Holt, K. E., Fiol, G. D., Baccarelli, A., & Allen, C. G. (2024) · Nature Medicine · doi:10.1038/s41591-024-03098-0 · Cited by 99 · see citing works

Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort

Lakeman, I. M. M., Rodríguez‐Girondo, M., Lee, A., Ruiter, R., Stricker, B. H. C., Wijnant, S. R. A., Kavousi, M., Antoniou, A. C., Schmidt, M. K., Uitterlinden, A. G., et al. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-0884-4 · Cited by 85 · see citing works

Risk-based breast cancer screening strategies in women

Harkness, E. F., Astley, S., & Evans, D. G. (2019) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2019.11.005 · Cited by 82 · see citing works

Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study

Callender, T., Emberton, M., Stephen Morris, A., Eeles, R. A., Kote‐Jarai, Z., Pharoah, P. D. P., & Pashayan, N. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002998 · Cited by 79 · see citing works

The emerging field of polygenic risk scores and perspective for use in clinical care

Yanes, T., McInerney-Leo, A. M., Law, M. H., & Cummings, S. A. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa136 · Cited by 75 · see citing works

Prospective evaluation of a breast-cancer risk model integrating classical risk factors and polygenic risk in 15 cohorts from six countries

Hurson, A. N., Choudhury, P. P., Gao, C., Hüsing, A., Eriksson, M., Shi, M., Scott, C., Carter, B. D., Martin, K., Harkness, E., et al. (2021) · International Journal of Epidemiology · doi:10.1093/ije/dyab036 · Cited by 75 · see citing works

Psychosocial and behavioral outcomes of genomic testing in cancer: a systematic review

Yanes, T., Willis, A. M., Meiser, B., Tucker, K., & Best, M. C. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0257-5 · Cited by 73 · see citing works

Personalizing Breast Cancer Screening Based on Polygenic Risk and Family History

van den Broek, J. J., Schechter, C. B., van Ravesteyn, N. T., Janssens, A. C. J. W., Wolfson, M. C., Trentham‐Dietz, A., Simard, J., Easton, D. F., Mandelblatt, J. S., Kraft, P., et al. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa127 · Cited by 71 · see citing works

Epidemiology of Breast Cancer

Shang, C., & Xu, D. (2022) · ONCOLOGIE · doi:10.32604/oncologie.2022.027640 · Cited by 67 · see citing works

Cost-Effectiveness of Risk-Stratified Colorectal Cancer Screening Based on Polygenic Risk: Current Status and Future Potential

Naber, S. K., Kundu, S., Kuntz, K. M., Dotson, W. D., Williams, M. S., Zauber, A. G., Calonge, N., Zallen, D. T., Ganiats, T. G., Webber, E. M., et al. (2019) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkz086 · Cited by 64 · see citing works

Integrating genome-wide polygenic risk scores and non-genetic risk to predict colorectal cancer diagnosis using UK Biobank data: population based cohort study

Briggs, S., Law, P., East, J. E., Wordsworth, S., Dunlop, M. G., Houlston, R. S., Hippisley‐Cox, J., & Tomlinson, I. P. M. (2022) · BMJ · doi:10.1136/bmj-2022-071707 · Cited by 64 · see citing works

Advancing precision public health using human genomics: examples from the field and future research opportunities

Roberts, M. C., Fohner, A. E., Landry, L. G., Olstad, D. L., Smit, A. K., Turbitt, E., & Allen, C. G. (2021) · Genome Medicine · doi:10.1186/s13073-021-00911-0 · Cited by 64 · see citing works

Prediction models for depression risk among older adults: systematic review and critical appraisal

Tan, J., Ma, C., Zhu, C., Wang, Y., Zou, X., Li, H., Li, J., He, Y., & Wu, C. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101803 · Cited by 62 · see citing works

Clinical use of polygenic risk scores: current status, barriers and future directions

Kullo, I. J. (2025) · Nature Reviews Genetics · doi:10.1038/s41576-025-00900-8 · Cited by 68 · see citing works

Systematic Review of the Cost Effectiveness of Breast Cancer Prevention, Screening, and Treatment Interventions

Jayasekera, J. C., & Mandelblatt, J. S. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.01525 · Cited by 61 · see citing works

Benefit, Harm, and Cost-effectiveness Associated With Magnetic Resonance Imaging Before Biopsy in Age-based and Risk-stratified Screening for Prostate Cancer

Callender, T., Emberton, M., Stephen Morris, A., Pharoah, P. D. P., & Pashayan, N. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.37657 · Cited by 61 · see citing works

Attitudes towards risk-stratified breast cancer screening among women in England: A cross-sectional survey

Ghanouni, A., Sanderson, S. C., Pashayan, N., Renzi, C., von Wagner, C., & Waller, J. (2019) · Journal of Medical Screening · doi:10.1177/0969141319883662 · Cited by 60 · see citing works

Women’s Views on Multifactorial Breast Cancer Risk Assessment and Risk-Stratified Screening: A Population-Based Survey from Four Provinces in Canada

Mbuya-Bienge, C., Pashayan, N., Brooks, J. D., Dorval, M., Chiquette, J., Eloy, L., Turgeon, A., Lambert-Côté, L., Paquette, J., Lévesque, E., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020095 · Cited by 58 · see citing works

Early detection of melanoma: a consensus report from the Australian Skin and Skin Cancer Research Centre Melanoma Screening Summit

Janda, M., Cust, A. E., Neale, R. Ε., Aitken, J. F., Baade, P. D., Green, A. C., Khosrotehrani, K., Mar, V., Soyer, H. P., & Whiteman, D. C. (2020) · Australian and New Zealand Journal of Public Health · doi:10.1111/1753-6405.12972 · Cited by 57 · see citing works

Distinct temporal trends in breast cancer incidence from 1997 to 2016 by molecular subtypes: a population-based study of Scottish cancer registry data

Mesa‐Eguiagaray, I., Wild, S. H., Rosenberg, P. S., Bird, S. M., Brewster, D., Hall, P. S., Cameron, D., Morrison, D. S., & Figueroa, J. D. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0938-z · Cited by 54 · see citing works

Financial Burden of Hepatocellular Carcinoma Screening in Patients With Cirrhosis

Narasimman, M., Hernáez, R., Cerda, V., Lee, M., Yekkaluri, S., Khan, A., Sood, A., Gurley, T., Quirk, L., Liu, Y., et al. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.07.018 · Cited by 54 · see citing works

Risk-Based vs Annual Breast Cancer Screening

Esserman, L. J., Fiscalini, A. S., Naeim, A., Veer, L. J. V., Kaster, A., Scheuner, M. T., LaCroix, A. Z., Borowsky, A. D., Anton‐Culver, H., Olopade, O. I., et al. (2025) · JAMA · doi:10.1001/jama.2025.24784 · Cited by 54 · see citing works

Personalized breast cancer screening strategies: A systematic review and quality assessment

Román, M., Sala, M., Domingo, L., Posso, M., Louro, J., & Castells, X. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226352 · Cited by 54 · see citing works

Breast Cancer Risk Assessment and Primary Prevention Advice in Primary Care: A Systematic Review of Provider Attitudes and Routine Behaviours

Hindmarch, S., Hawkes, R. E., Howell, S. J., Gorman, L. S., & French, D. (2021) · Cancers · doi:10.3390/cancers13164150 · Cited by 54 · see citing works

Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium

Robbins, H. A., Ferreiro-Iglesias, A., Waterboer, T., Brenner, N., Nygård, M., Bender, N., Schroeder, L., Hildesheim, A., Pawlita, M., DʼSouza, G., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.01785 · Cited by 53 · see citing works

Dutch women’s intended participation in a risk-based breast cancer screening and prevention programme: a survey study identifying preferences, facilitators and barriers

Rainey, L., van der Waal, D., & Broeders, M. J. M. (2020) · BMC Cancer · doi:10.1186/s12885-020-07464-2 · Cited by 52 · see citing works

Risk-Adapted Starting Age of Screening for Relatives of Patients With Breast Cancer

Mukama, T., Kharazmi, E., Xu, X., Sundquist, K., Sundquist, J., Brenner, H., & Fallah, M. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.3876 · Cited by 49 · see citing works

Barriers in Latin America for the management of locally advanced breast cancer

Pinto, J. A., Pinillos, L., Villarreal-Garza, C. M., Morante, Z., Villarán, M., Mejía, G., Caglevic, C., Aguilar, A., Fajardo, W., Torres, F. A. U., et al. (2019) · ecancermedicalscience · doi:10.3332/ecancer.2019.897 · Cited by 48 · see citing works

Towards a cancer mission in Horizon Europe: recommendations

Berns, A. J. M., Ringborg, U. K., Celis, J. E., Heitor, M. V., Aaronson, N. K., Abou‐Zeid, N., Adami, H., Apostolidis, K., Baumann, M. A., Bardelli, A., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12763 · Cited by 47 · see citing works

Risk stratified breast cancer screening: UK healthcare policy decision-making stakeholders’ views on a low-risk breast screening pathway

McWilliams, L., Woof, V. G., Donnelly, L. S., Howell, A., Evans, D. G., & French, D. (2020) · BMC Cancer · doi:10.1186/s12885-020-07158-9 · Cited by 43 · see citing works

External Validation of Risk Prediction Models Incorporating Common Genetic Variants for Incident Colorectal Cancer Using UK Biobank

Saunders, C. L., Kilian, B., Thompson, D. J., McGeoch, L. J., Griffin, S. J., Antoniou, A. C., Emery, J. D., Walter, F. M., Dennis, J., Yang, X., et al. (2020) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-19-0521 · Cited by 42 · see citing works

The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening

Benafif, S., Raghallaigh, H. N., McGrowder, E. H., Saunders, E. J., Brook, M. N., Saya, S., Rageevakumar, R., Wakerell, S., James, D., Chamberlain, A., et al. (2021) · British Journal of Urology · doi:10.1111/bju.15535 · Cited by 42 · see citing works

Can polygenic risk scores contribute to cost-effective cancer screening? A systematic review

Dixon, P., Keeney, E., Taylor, J. C., Wordsworth, S., & Martin, R. M. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2022.04.020 · Cited by 41 · see citing works

Cost-Effectiveness of Personalized Screening for Colorectal Cancer Based on Polygenic Risk and Family History

Cenin, D. R., Naber, S. K., de Weerdt, A. C., Jenkins, M. A., Preen, D. B., Ee, H. C., O'Leary, P. C., & Lansdorp‐Vogelaar, I. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-1123 · Cited by 40 · see citing works

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Coignard, J., Lush, M. J., Beesley, J., O’Mara, T. A., Dennis, J., Tyrer, J. P., Barnes, D. R., McGuffog, L., Leslie, G., Bolla, M. K., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20496-3 · Cited by 41 · see citing works

Change in effectiveness of mammography screening with decreasing breast cancer mortality: a population-based study

Christiansen, S. R., Autier, P., & Støvring, H. (2022) · European Journal of Public Health · doi:10.1093/eurpub/ckac047 · Cited by 39 · see citing works

Understanding polygenic models, their development and the potential application of polygenic scores in healthcare

de Villiers, C. B., Kroese, M., & Moorthie, S. A. (2020) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106763 · Cited by 37 · see citing works

Cost-effectiveness of using artificial intelligence versus polygenic risk score to guide breast cancer screening

Mital, S., & Nguyen, H. V. (2022) · BMC Cancer · doi:10.1186/s12885-022-09613-1 · Cited by 38 · see citing works

Using Big Data and Predictive Analytics to Determine Patient Risk in Oncology

Parikh, R. B., Gdowski, A., Patt, D. A., Hertler, A. A., Mermel, C. H., & Bekelman, J. E. (2019) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_238891 · Cited by 38 · see citing works

Population-based Genetic Testing for Precision Prevention

Evans, O., & Manchanda, R. (2020) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-20-0002 · Cited by 38 · see citing works

The diagnosis that should speak its name: why it is ethically right to diagnose and treat personality disorder during adolescence

Hutsebaut, J., Clarke, S. L., & Chanen, A. M. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1130417 · Cited by 36 · see citing works

European women’s perceptions of the implementation and organisation of risk-based breast cancer screening and prevention: a qualitative study

Rainey, L., van der Waal, D., Jervaeus, A., Donnelly, L. S., Evans, D. G., Hammarström, M., Hall, P. N., Wengström, Y., & Broeders, M. J. M. (2020) · BMC Cancer · doi:10.1186/s12885-020-06745-0 · Cited by 36 · see citing works

Acceptability of risk‐stratified population screening across cancer types: Qualitative interviews with the Australian public

Dunlop, K. L. A., Rankin, N. M., Smit, A. K., Salgado, Z., Newson, A. J., Keogh, L. A., & Cust, A. E. (2021) · Health Expectations · doi:10.1111/hex.13267 · Cited by 36 · see citing works

Cost effectiveness of breast cancer screening and prevention: a systematic review with a focus on risk-adapted strategies

Mühlberger, N., Sroczynski, G., Gogollari, A., Jahn, B., Pashayan, N., Steyerberg, E. W., Widschwendter, M., & Siebert, U. (2021) · The European Journal of Health Economics · doi:10.1007/s10198-021-01338-5 · Cited by 36 · see citing works

Comprehensive Inherited Risk Estimation for Risk-Based Breast Cancer Screening in Women

Mars, N., Kerminen, S., Tamlander, M., Pirinen, M., Jakkula, E., Aaltonen, K., Meretoja, T. J., Heinävaara, S. H., Widén, E., Ripatti, S., et al. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.23.00295 · Cited by 35 · see citing works

Of Screening, Stratification, and Scores

Knoppers, B. M., Bernier, A., Moreno, P. G., & Pashayan, N. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11080736 · Cited by 35 · see citing works

UK Women’s Views of the Concepts of Personalised Breast Cancer Risk Assessment and Risk-Stratified Breast Screening: A Qualitative Interview Study

Jones, C. K., Scott, S. E., & Waller, J. (2021) · Cancers · doi:10.3390/cancers13225813 · Cited by 35 · see citing works

Targeting lung cancer screening to individuals at greatest risk: the role of genetic factors

Lebrett, M. B., Crosbie, E. J., Smith, M. J., Woodward, E. R., Evans, D. G., & Crosbie, P. A. J. (2021) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2020-107399 · Cited by 34 · see citing works

A Decision Analysis Evaluating Screening for Kidney Cancer Using Focused Renal Ultrasound

Rossi, S. H., Klatte, T., Usher‐Smith, J. A., Fife, K. M., Welsh, S. J., Dabestani, S., Bex, A., Nicol, D. L., Nathan, P., Stewart, G. D., et al. (2019) · European Urology Focus · doi:10.1016/j.euf.2019.09.002 · Cited by 33 · see citing works

Cost effectiveness analysis of a polygenic risk tailored breast cancer screening programme in Singapore

Wong, J. Z. Y., Chai, J. H., Yeoh, Y. S., Riza, N. K. M., Liu, J. X., Teo, Y.-Y., Wee, H. L., & Hartman, M. (2021) · BMC Health Services Research · doi:10.1186/s12913-021-06396-2 · Cited by 31 · see citing works

Barriers and Attitudes toward Breast Cancer Screening among Omani Women

Al-Azri, M. H., Al-Rubaie, K., Al-Ghafri, S., Al‐Hinai, M., & Panchatcharam, S. M. (2020) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2020.21.5.1339 · Cited by 29 · see citing works

Cost‐effectiveness of risk‐based breast cancer screening: A systematic review

Khan, S. A., Hernández-Villafuerte, K., Muchandifunga Trust Muchadeyi, & Schlander, M. (2021) · International Journal of Cancer · doi:10.1002/ijc.33593 · Cited by 30 · see citing works

Polygenic risk scores: the future of cancer risk prediction, screening, and precision prevention

Wang, Y., Zhu, M., Ma, H., & Shen, H. (2021) · Medical Review · doi:10.1515/mr-2021-0025 · Cited by 32 · see citing works

Should Age-Dependent Absolute Risk Thresholds Be Used for Risk Stratification in Risk-Stratified Breast Cancer Screening?

Pashayan, N., Antoniou, A. C., Lee, A., Wolfson, M. C., Chiquette, J., Eloy, L., Eisen, A. F., Stockley, T. L., Nabi, H., Brooks, J. D., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11090916 · Cited by 29 · see citing works

BREAst screening Tailored for HEr (BREATHE)—A study protocol on personalised risk-based breast cancer screening programme

Liu, J. X., Ho, P. J., Tan, T. H. L., Yeoh, Y. S., Chew, Y. J., Riza, N. K. M., Khng, A. J., Goh, S.-A., Wang, Y., Oh, H. B., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265965 · Cited by 29 · see citing works

Implementation Challenges for Risk-Stratified Screening in the Era of Precision Medicine

Roberts, M. C. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.1940 · Cited by 29 · see citing works

Comparison of breast density assessment between human eye and automated software on digital and synthetic mammography: Impact on breast cancer risk

Boulch, M. L., Bekhouche, A., Kermarrec, É., Milon, A., Wahab, C. A., Zilberman, S., Chabbert‐Buffet, N., & Thomassin‐Naggara, I. (2020) · Diagnostic and Interventional Imaging · doi:10.1016/j.diii.2020.07.004 · Cited by 28 · see citing works

A community jury study exploring the public acceptability of using risk stratification to determine eligibility for cancer screening

Dennison, R. A., Boscott, R. A., Thomas, R., Griffin, S. J., Harrison, H., John, S. D., Moorthie, S. A., Stephen Morris, A., Rossi, S. H., Stewart, G. D., et al. (2022) · Health Expectations · doi:10.1111/hex.13522 · Cited by 28 · see citing works

Risk stratification in breast cancer screening: Cost‐effectiveness and harm‐benefit ratios for low‐risk and high‐risk women

Sankatsing, V. D. V., van Ravesteyn, N. T., Heijnsdijk, E. A. M., Broeders, M. J. M., & de Koning, H. J. (2020) · International Journal of Cancer · doi:10.1002/ijc.33126 · Cited by 27 · see citing works

Radial scars and complex sclerosing lesions on core needle biopsy of the breast: upgrade rates and long-term outcomes

Quinn, E. M., Dunne, E., Flanagan, F. L., Mahon, S., Stokes, M., Barry, M. J., Kell, M. R., & Walsh, S. M. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05806-z · Cited by 27 · see citing works

Supervised Two-Dimensional Functional Principal Component Analysis with Time-to-Event Outcomes and Mammogram Imaging Data

Jiang, S., Cao, J., ROSNER, B. A., & Colditz, G. A. (2021) · Biometrics · doi:10.1111/biom.13611 · Cited by 27 · see citing works

Breast cancer polygenic risk scores in the clinical cancer genetic counseling setting: Current practices and impact on patient management

McGuinness, M., Fassi, E., Wang, C., Hacking, C. C., & Ellis, V. (2020) · Journal of Genetic Counseling · doi:10.1002/jgc4.1347 · Cited by 26 · see citing works

Potential of polygenic risk scores for improving population estimates of women’s breast cancer genetic risks

Wolfson, M. C., Gribble, S., Pashayan, N., Easton, D. F., Antoniou, A. C., Lee, A., van Katwyk, S., & Simard, J. (2021) · Genetics in Medicine · doi:10.1038/s41436-021-01258-y · Cited by 26 · see citing works

Risk prediction models for breast cancer: a systematic review

Zheng, Y.-D., Li, J., Wu, Z., Li, H., Cao, M., Li, N., & He, J. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-055398 · Cited by 20 · see citing works

Use of Breast Cancer Risk Factors to Identify Risk-Adapted Starting Age of Screening in China

Zheng, Y., Dong, X., Jiang, L., Qin, C., Xu, Y., Wang, F., Cao, W., Xia, C., Yu, Y., Zhao, L., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.41441 · Cited by 24 · see citing works

Epidemiology of Breast Cancer in Sub-Saharan Africa

Adeoye, P. A. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.109361 · Cited by 24 · see citing works

Envisioning Implementation of a Personalized Approach in Breast Cancer Screening Programs: Stakeholder Perspectives

Esquivel-Sada, D., Lévesque, E., Hagan, J., Knoppers, B. M., & Simard, J. (2019) · Healthcare policy · doi:10.12927/hcpol.2019.26072 · Cited by 24 · see citing works

Acceptability and potential impact on uptake of using different risk stratification approaches to determine eligibility for screening: A population‐based survey

Usher‐Smith, J. A., Harvey-Kelly, L. L. W., Rossi, S. H., Harrison, H., Griffin, S. J., & Stewart, G. D. (2020) · Health Expectations · doi:10.1111/hex.13175 · Cited by 23 · see citing works

Trade-Offs Between Harms and Benefits of Different Breast Cancer Screening Intervals Among Low-Risk Women

van Ravesteyn, N. T., Schechter, C. B., Hampton, J. M., Alagöz, O., van den Broek, J. J., Kerlikowske, K. M., Mandelblatt, J. S., Miglioretti, D. L., Sprague, B. L., Stout, N. K., et al. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa218 · Cited by 23 · see citing works

Key Points in Remote-Controlled Drug Delivery: From the Carrier Design to Clinical Trials

Voronin, D. V., Abalymov, A. A., Svenskaya, Y. I., & Lomova, M. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179149 · Cited by 24 · see citing works

Healthcare professionals’ views following implementation of risk stratification into a national breast cancer screening programme

Hawkins, R. L., McWilliams, L., Ulph, F., Evans, D. G., & French, D. (2022) · BMC Cancer · doi:10.1186/s12885-022-10134-0 · Cited by 23 · see citing works

Benefits and harms of polygenic risk scores in organised cancer screening programmes: a cost-effectiveness analysis

Xia, C., Xu, Y., He, L., He, S., & Chen, W. (2024) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2024.101012 · Cited by 23 · see citing works

Identifying Women at High Risk for Breast Cancer Using Data From the Electronic Health Record Compared With Self-Report

Jiang, X., McGuinness, J. E., Sin, M., Silverman, T. B., Kukafka, R., & Crew, K. D. (2019) · JCO Clinical Cancer Informatics · doi:10.1200/cci.18.00072 · Cited by 23 · see citing works

Introducing a low-risk breast screening pathway into the NHS Breast Screening Programme: Views from healthcare professionals who are delivering risk-stratified screening

Woof, V. G., McWilliams, L., Donnelly, L. S., Howell, A., Evans, D. G., Maxwell, A., & French, D. (2021) · Women s Health · doi:10.1177/17455065211009746 · Cited by 23 · see citing works

Implementing Multifactorial Risk Assessment with Polygenic Risk Scores for Personalized Breast Cancer Screening in the Population Setting: Challenges and Opportunities

Walker, M. J., Blackmore, K. M., Chang, A., Lambert-Côté, L., Turgeon, A., Antoniou, A. C., Bell, K. A., Broeders, M. J. M., Brooks, J. D., Carver, T. J., et al. (2024) · Cancers · doi:10.3390/cancers16112116 · Cited by 22 · see citing works

Risk prediction models for esophageal cancer: A systematic review and critical appraisal

Li, H., Sun, D., Cao, M., He, S., Zheng, Y., Yu, X., Wu, Z. L., Lei, L., Peng, J., Li, J., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.4226 · Cited by 22 · see citing works

Risk-Stratified Breast Cancer Screening Incorporating a Polygenic Risk Score: A Survey of UK General Practitioners’ Knowledge and Attitudes

Ayoub, A., Lapointe, J., Nabi, H., & Pashayan, N. (2023) · Genes · doi:10.3390/genes14030732 · Cited by 22 · see citing works

Revisiting the standard blueprint for biomarker development to address emerging cancer early detection technologies

Etzioni, R., Gulati, R., Patriotis, C., Rutter, C. M., Zheng, Y., Srivastava, S., & Feng, Z. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad227 · Cited by 23 · see citing works

The ethics of risk-stratified cancer screening

Dennison, R. A., Usher‐Smith, J. A., & John, S. D. (2023) · European Journal of Cancer · doi:10.1016/j.ejca.2023.03.023 · Cited by 21 · see citing works

Predictive models of Alzheimer’s disease dementia risk in older adults with mild cognitive impairment: a systematic review and critical appraisal

Wang, X., Zhou, S., Ye, N., Li, Y., Zhou, P., Gao, C., & Hu, H. Z. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-05044-8 · Cited by 22 · see citing works

Toward a Population-Based Breast Cancer Risk Stratification Approach? The Needs and Concerns of Healthcare Providers

Blouin-Bougie, J., Amara, N., & Simard, J. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060540 · Cited by 21 · see citing works

Toward Risk-Stratified Breast Cancer Screening: Considerations for Changes in Screening Guidelines

Gierach, G. L., Choudhury, P. P., & García‐Closas, M. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.3820 · Cited by 21 · see citing works

Evaluating the performance of the Breast and Ovarian Analysis of Disease Incidence Algorithm model in predicting 10-year breast cancer risks in UK Biobank

Petitjean, C., Wilcox, N., Ficorella, L., Dennis, J., Tyrer, J. P., Lush, M. J., Simard, J., Easton, D. F., Antoniou, A. C., & Yang, X. (2024) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djae335 · Cited by 20 · see citing works

Utility of machine learning in developing a predictive model for early-age-onset colorectal neoplasia using electronic health records

Hussan, H., Zhao, J., Badu-Tawiah, A. K., Stanich, P. P., Tabung, F. K., Gray, D. M., Ma, Q., Kalady, M. F., & Clinton, S. K. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265209 · Cited by 20 · see citing works

Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model

Pashayan, N., Stephen Morris, A., Gilbert, F. J., & Pharoah, P. (2018) · Apollo (University of Cambridge) · doi:10.17863/cam.25096

The cost-effectiveness of risk-stratified breast cancer screening in the UK

Hill, H. R., Kearns, B., Pashayan, N., Roadevin, C., Sasieni, P. D., Offman, J., & Duffy, S. W. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02461-1 · Cited by 24 · see citing works

Estimating the cost-effectiveness of risk stratified breast cancer screening in the UK

Hill, H. R., Kearns, B., Duffy, S. W., Pashayan, N., Sasieni, P. D., & Offman, J. (2024) · Figshare · doi:10.15131/shef.data.25219262

Risk stratification in breast cancer screening: Cost‐effectiveness and harm‐benefit ratios for low‐risk and high‐risk women

Sankatsing, V. D. V., van Ravesteyn, N. T., Heijnsdijk, E. A. M., Broeders, M. J. M., & de Koning, H. J. (2020) · International Journal of Cancer · doi:10.1002/ijc.33126 · Cited by 27 · see citing works

Targeted breast screening could reduce overdiagnosis and be more cost effective, study finds

Thornton, J. (2018) · BMJ · doi:10.1136/bmj.k3009